References
- Grill S, Rusterholz C, Zanetti-Dällenbach R, et al. Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 2009;7:70–84
- Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
- Delić R, Štefanović M. Optimal laboratory panel for predicting preeclampsia. J Matern Fetal Neonatal Med 2010;23:96–102
- Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–22
- Nomenclature Committee of the International Union of Biochemistry (NC-IUB). “Units of Enzyme Activity”. Eur J Biochem 1979;97:319–20
- Levine RJ, Lindheimer MD. First-trimester prediction of early preeclampsia: a possibility at last! Hypertension 2009;53:747–8
- Nowitzki ER. Predicting preeclampsia. Available from http://www.uptodate.com/predictingpreeclampsia via the INTERNET [last accessed 11 Dec 2012]
- Angeli F, Angeli E, Reboldi G, Verdecchia P. Hypertensive disorders during pregnancy: clinical applicability of risk prediction models. J Hypertens 2011;29:2320–3
- Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012;119:1234–42
- Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021–38
- Hagmann H, Thadhani R, Benzing T, et al. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem 2012;58:837–45
- Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci 2012;122:43–52
- Lapaire O, Shennan A, Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol 2010;151:122–9
- Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3–18
- Buhimschi CS, Magloire L, Funai E, et al. Fractional excretion of angiogenic factors in women with severe preeclampsia. Obstet Gynecol 2006;107:1103–13
- Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161.e1–11
- Laughon SK, Catov J, Powers RW, et al. First trimester uric acid and adverse pregnancy outcomes. Am J Hypertens. 2011;24:489–95
- Bainbridge SA, Roberts JM, von Versen-Höynck F, et al. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol 2009;297:C440–50
- Bainbridge SA, Deng JS, Roberts JM. Increased xanthine oxidase in the skin of preeclamptic women. Reprod Sci 2009;16:468–78
- Bainbridge SA, von Versen-Höynck F, Roberts JM. Uric acid inhibits placental system A amino acid uptake. Placenta 2009;30:195–200
- Sunderji S, Gaziano E, Wothe D, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010;202:40.e1–7
- Woolcock J, Hennessy A, Xu B, et al. Soluble Flt-1 as a diagnostic marker of preeclampsia. Aust N Z J Obstet Gynaecol 2008;48:64–70